skip to main |
skip to sidebar
The study, which wraps up in a few months, is utilizing a compound derived from the saliva of vampire bats and testing its effectiveness in reducing the risk of brain damage after the onset of an acute stroke. If approved, the drug will triple the time period for initiating emergency stroke treatment and offer other important advantages over other medications currently in use, including the only Food and Drug Administration-approved stroke drug.
HealthNewsDigest.com
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.